These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9145 related articles for article (PubMed ID: 11530496)

  • 21. The potential of exosomes in immunotherapy of cancer.
    Chaput N; Taïeb J; Schartz N; Flament C; Novault S; André F; Zitvogel L
    Blood Cells Mol Dis; 2005; 35(2):111-5. PubMed ID: 16027014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination with dendritic cells pulsed in vitro with tumor antigen conjugated to cholera toxin efficiently induces specific tumoricidal CD8+ cytotoxic lymphocytes dependent on cyclic AMP activation of dendritic cells.
    Sun JB; Eriksson K; Li BL; Lindblad M; Azem J; Holmgren J
    Clin Immunol; 2004 Jul; 112(1):35-44. PubMed ID: 15207780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosomes for immunotherapy of cancer.
    Chaput N; Schartz NE; Andre F; Zitvogel L
    Adv Exp Med Biol; 2003; 532():215-21. PubMed ID: 12908560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic Cells and Cancer Immunity.
    Gardner A; Ruffell B
    Trends Immunol; 2016 Dec; 37(12):855-865. PubMed ID: 27793569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
    Hao S; Yuan J; Xiang J
    J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor Effect of KML-B-Treated Dendritic Cells via Induction of Lymphocyte Activation.
    Kim JJ; Hwang YH; Kang KY; Lee SJ; Kim JB; Choi J; Yee ST
    J Immunol Res; 2017; 2017():2471627. PubMed ID: 28634588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of exosomes in immune regulation.
    Li XB; Zhang ZR; Schluesener HJ; Xu SQ
    J Cell Mol Med; 2006; 10(2):364-75. PubMed ID: 16796805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exosomes from Dendritic Cells Loaded with Chaperone-Rich Cell Lysates Elicit a Potent T Cell Immune Response Against Intracranial Glioma in Mice.
    Bu N; Wu H; Zhang G; Zhan S; Zhang R; Sun H; Du Y; Yao L; Wang H
    J Mol Neurosci; 2015 Jul; 56(3):631-43. PubMed ID: 25680514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosome-based immunotherapy.
    Chaput N; Taïeb J; Schartz NE; André F; Angevin E; Zitvogel L
    Cancer Immunol Immunother; 2004 Mar; 53(3):234-9. PubMed ID: 14727085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dendritic cell vaccines for cancer immunotherapy.
    Timmerman JM; Levy R
    Annu Rev Med; 1999; 50():507-29. PubMed ID: 10073291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accumulation of MFG-E8/lactadherin on exosomes from immature dendritic cells.
    Véron P; Segura E; Sugano G; Amigorena S; Théry C
    Blood Cells Mol Dis; 2005; 35(2):81-8. PubMed ID: 15982908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA loading of leukemic antigens into cord blood-derived dendritic cells for immunotherapy.
    Hsu AK; Kerr BM; Jones KL; Lock RB; Hart DN; Rice AM
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):855-67. PubMed ID: 16864056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy.
    van Broekhoven CL; Parish CR; Demangel C; Britton WJ; Altin JG
    Cancer Res; 2004 Jun; 64(12):4357-65. PubMed ID: 15205352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosomal cancer immunotherapy is independent of MHC molecules on exosomes.
    Hiltbrunner S; Larssen P; Eldh M; Martinez-Bravo MJ; Wagner AK; Karlsson MC; Gabrielsson S
    Oncotarget; 2016 Jun; 7(25):38707-38717. PubMed ID: 27231849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunotherapy against tumor with dendritic cell sensitized by necrotic tumor tissue after microwave coagulation therapy].
    Yao LC; Yang RJ
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2552-6. PubMed ID: 18067832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospects for exosomes in immunotherapy of cancer.
    Mignot G; Roux S; Thery C; Ségura E; Zitvogel L
    J Cell Mol Med; 2006; 10(2):376-88. PubMed ID: 16796806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients.
    Bonehill A; Van Nuffel AM; Corthals J; Tuyaerts S; Heirman C; François V; Colau D; van der Bruggen P; Neyns B; Thielemans K
    Clin Cancer Res; 2009 May; 15(10):3366-75. PubMed ID: 19417017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosome-based tumor antigens-adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA.
    Morishita M; Takahashi Y; Matsumoto A; Nishikawa M; Takakura Y
    Biomaterials; 2016 Dec; 111():55-65. PubMed ID: 27723556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of protective CTL immunity against peptide transporter TAP-deficient tumors through dendritic cell vaccination.
    Chambers B; Grufman P; Fredriksson V; Andersson K; Roseboom M; Laban S; Camps M; Wolpert EZ; Wiertz EJ; Offringa R; Ljunggren HG; van Hall T
    Cancer Res; 2007 Sep; 67(18):8450-5. PubMed ID: 17875682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models.
    Kretz-Rommel A; Qin F; Dakappagari N; Torensma R; Faas S; Wu D; Bowdish KS
    J Immunother; 2007 Oct; 30(7):715-26. PubMed ID: 17893564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 458.